we examined the possibility of continuing oxazaphosphorine therapy in patients with previously documented cyclophosphamide- or ifosfamide-induced hematuria by concomitant use of the uroprotective agent , mesna .
C0010583
cyclophosphamide
C0020823
ifosfamide